Figure 1.
Adjusted geometric mean change (95% CI) in log-transformed UACR from baseline to end of treatment at week 14. ∗Not significant after Bonferroni correction for multiple analyses. CI, confidence interval; EMPA, empagliflozin; PBO, placebo; UACR, urine albumin-to-creatinine ratio; VICA, vicadrostat.
